Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Malignant Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00958737
What this trial is testing

Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 2,000
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Study completedNCT01105377
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
National Cancer Institute (NCI) 47
Not applicableActive Not RecruitingNCT02394834
What this trial is testing

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Takeda 757
Testing effectiveness (Phase 2)Study completedNCT00454116
What this trial is testing

A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients

Who this might be right for
Colorectal Cancer
Genzyme, a Sanofi Company 106
Testing effectiveness (Phase 2)Ended earlyNCT03645876
What this trial is testing

SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 12
Not applicableStudy completedNCT06212817
What this trial is testing

Dietary Fiber Before Colorectal Cancer Surgery

Who this might be right for
Colorectal Cancer
Wageningen University 54
Testing effectiveness (Phase 2)Study completedNCT00826540
What this trial is testing

Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
Alliance for Clinical Trials in Oncology 83
Large-scale testing (Phase 3)UnknownNCT04642924
What this trial is testing

SGM-101 in Locally Advanced and Recurrent Rectal Cancer

Who this might be right for
Rectal CancerRecurrent Rectal Cancer
Leiden University Medical Center 203
Testing effectiveness (Phase 2)Looking for participantsNCT05692024
What this trial is testing

COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER

Who this might be right for
Colorectal CancerCoffeeGastrointestinal Microbiome+4 more
Massachusetts General Hospital 80
Not applicableUnknownNCT03962088
What this trial is testing

Timisnar - Biomarkers Substudy (Timisnar-mirna)

Who this might be right for
Rectal Cancer
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria 200
Not applicableWithdrawnNCT00835055
What this trial is testing

Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

Who this might be right for
Rectal Cancer
St. Claraspital AG
Testing effectiveness (Phase 2)Looking for participantsNCT07398326
What this trial is testing

Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Shanghai Changzheng Hospital 37
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Not applicableStudy completedNCT03602417
What this trial is testing

Flare Type Self-expandable Metal Stent for Malignant Colorectal Obstruction

Who this might be right for
Colorectal Cancer
Kyungpook National University Hospital 61
Not applicableLooking for participantsNCT04796818
What this trial is testing

An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+4 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Ended earlyNCT00932724
What this trial is testing

CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cytavis Biopharma GmbH 77
Testing effectiveness (Phase 2)Ended earlyNCT00037180
What this trial is testing

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Who this might be right for
Neoplasm MetastasisColorectal Neoplasms
Pfizer 212
Not applicableUnknownNCT03030508
What this trial is testing

Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients

Who this might be right for
Colorectal CancerCapecitabine
Shanghai Changzheng Hospital 300
Not applicableStudy completedNCT03965325
What this trial is testing

FOcUs on Colorectal CAncer oUtcomes: Long-Term Study

Who this might be right for
Colorectal Cancer
IHU Strasbourg 133
Next Page